Ultragenyx: Leading the Future of Rare Disease Medicine with ESG Commitment May 29, 2023 by Mathieu Maurice Introducing Ultragenyx Pharmaceutical Inc, a visionary biopharmaceutical company dedicated to revolutionizing the field of rare and ultrarare disease treatments. Today, we proudly unveil our highly anticipated second annual ESG report, …